NYSE - Delayed Quote USD

Centene Corporation (CNC)

75.68 -0.51 (-0.67%)
At close: April 25 at 4:00 PM EDT
77.90 +2.22 (+2.93%)
Pre-Market: 6:25 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
153,999,000.00
153,999,000.00
144,547,000.00
125,982,000.00
111,115,000.00
Cost of Revenue
136,684,000.00
136,684,000.00
127,891,000.00
111,783,000.00
95,899,000.00
Gross Profit
17,315,000.00
17,315,000.00
16,656,000.00
14,199,000.00
15,216,000.00
Operating Expense
13,856,000.00
13,856,000.00
13,020,000.00
10,936,000.00
12,062,000.00
Operating Income
3,459,000.00
3,459,000.00
3,636,000.00
3,263,000.00
3,154,000.00
Net Non Operating Interest Income Expense
-725,000.00
-725,000.00
-665,000.00
-665,000.00
-728,000.00
Other Income Expense
864,000.00
864,000.00
-1,009,000.00
-785,000.00
347,000.00
Pretax Income
3,598,000.00
3,598,000.00
1,962,000.00
1,813,000.00
2,773,000.00
Tax Provision
899,000.00
899,000.00
760,000.00
477,000.00
979,000.00
Net Income Common Stockholders
2,702,000.00
2,702,000.00
1,202,000.00
1,347,000.00
1,808,000.00
Diluted NI Available to Com Stockholders
2,702,000.00
2,702,000.00
1,202,000.00
1,347,000.00
1,808,000.00
Basic EPS
4.51
4.97
2.09
2.31
3.17
Diluted EPS
4.51
4.95
2.07
2.28
3.12
Basic Average Shares
549,763.75
543,319.00
575,191.00
582,832.00
570,722.00
Diluted Average Shares
553,036.00
545,704.00
582,040.00
590,516.00
579,135.00
Total Operating Income as Reported
2,930,000.00
2,930,000.00
1,318,000.00
1,784,000.00
3,082,000.00
Total Expenses
150,540,000.00
150,540,000.00
140,911,000.00
122,719,000.00
107,961,000.00
Net Income from Continuing & Discontinued Operation
2,702,000.00
2,702,000.00
1,202,000.00
1,347,000.00
1,808,000.00
Normalized Income
2,054,000.00
2,054,000.00
1,820,517.00
1,925,466.63
1,583,491.00
Interest Expense
725,000.00
725,000.00
665,000.00
665,000.00
728,000.00
Net Interest Income
-725,000.00
-725,000.00
-665,000.00
-665,000.00
-728,000.00
EBIT
4,323,000.00
4,323,000.00
2,627,000.00
2,478,000.00
3,501,000.00
EBITDA
5,616,000.00
5,616,000.00
4,058,000.00
3,813,000.00
4,760,000.00
Reconciled Cost of Revenue
136,684,000.00
136,684,000.00
127,892,000.00
111,783,000.00
95,359,000.00
Reconciled Depreciation
1,293,000.00
1,293,000.00
1,430,000.00
1,335,000.00
1,259,000.00
Net Income from Continuing Operation Net Minority Interest
2,702,000.00
2,702,000.00
1,202,000.00
1,347,000.00
1,808,000.00
Total Unusual Items Excluding Goodwill
864,000.00
864,000.00
-1,009,000.00
-785,000.00
347,000.00
Total Unusual Items
864,000.00
864,000.00
-1,009,000.00
-785,000.00
347,000.00
Normalized EBITDA
4,752,000.00
4,752,000.00
5,067,000.00
4,598,000.00
4,413,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
216,000.00
216,000.00
-390,483.00
-206,533.37
122,491.00
12/31/2020 - 12/13/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MOH Molina Healthcare, Inc.
352.30
-4.11%
 
CI The Cigna Group
354.51
+0.63%
 
ELV Elevance Health, Inc.
539.68
+1.11%
 
HUM Humana Inc.
311.41
-1.45%
 
ALHC Alignment Healthcare, Inc.
5.16
-0.39%
 
CVS CVS Health Corporation
67.33
-0.65%
 
OSCR Oscar Health, Inc.
17.89
+1.71%
 
UNH UnitedHealth Group Incorporated
493.86
+1.35%
 
NEUE NeueHealth, Inc.
6.33
-1.94%
 
C1IC34.SA The Cigna Group
452.65
0.00%